The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2017

Filed:

Dec. 21, 2010
Applicants:

Louis H. Bookbinder, San Diego, CA (US);

Anirban Kundu, San Diego, CA (US);

Gregory I. Frost, Del Mar, CA (US);

Inventors:

Louis H. Bookbinder, San Diego, CA (US);

Anirban Kundu, San Diego, CA (US);

Gregory I. Frost, Del Mar, CA (US);

Assignee:

Halozyme, Inc., San Diego, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/24 (2006.01); C12N 9/26 (2006.01); A61K 9/00 (2006.01); A61K 38/47 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2474 (2013.01); A61K 9/0048 (2013.01); A61K 38/47 (2013.01); A61K 47/48215 (2013.01); C12Y 302/01035 (2013.01);
Abstract

Provided are soluble neutral active Hyaluronidase Glycoproteins (sHASEGP's), methods of manufacture, and their use to facilitate administration of other molecules or to alleviate glycosaminoglycan associated pathologies. Minimally active polypeptide domains of the soluble, neutral active sHASEGP domains are described that include asparagine-linked sugar moieties required for a functional neutral active hyaluronidase domain. Included are modified amino-terminal leader peptides that enhance secretion of sHASEGP. Sialated and pegylated forms of the sHASEGPs also are provided. Methods of treatment by administering sHASEGPs and modified forms thereof also are provided.


Find Patent Forward Citations

Loading…